Otitis media: Inflammation of the anatomical structures of the middle ear, which is most often caused by an infectious process. Symptoms include erythema and edema of the tympanic membrane, pain, and possibly fever.
Other specified/unspecified disorders of middle ear and mastoid
DOID EFO Endpoint Browser PheWeb
H8_MIDDMASTNAS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
90 |
4. Check minimum number of eventsNone |
90 |
5. Include endpointsNone |
90 |
6. Filter based on genotype QC (FinnGen only) |
88 |
Control definitions (FinnGen only)
- Control exclude
- H8_MIDDLEMASTOID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified/unspecified disorders of middle ear and mastoid
based on the number of shared cases.
Similar with more cases:
- Diseases of middle ear and mastoid
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 788 | 397 | 384 |
| Only index persons | 681 | 343 | 338 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 49.36 | 49.06 | 49.54 |
| Only index persons | 49.00 | 48.89 | 49.11 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 88 | 54 | 34 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 53.11 | 49.96 | 58.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 90
- Matched controls
- 899
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
108.5
81
*
J01DB01, ,
ATC
cefalexin; oral
+∞
99.1
76
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
97.3
75
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
97.3
75
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
92.1
72
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
82.3
66
*
WX110, ,
ICD-O-3
+∞
73.2
60
*
SAA01, ,
ICD-O-3
+∞
68.8
57
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
65.9
55
*
M03BX02, ,
ATC
tizanidine; oral
+∞
63.1
53
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
61.7
52
*
SAA02, ,
ICD-O-3
+∞
61.7
52
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
59.0
50
*
J01DA01, ,
ATC
[U] cefalexin
+∞
59.0
50
*
EB1AA, ,
ICD-O-3
+∞
54.9
47
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
54.9
47
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
52.2
45
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
52.2
45
*
K021, ,
ICD-O-3
+∞
49.6
43
*
GD1AA, ,
ICD-O-3
+∞
49.6
43
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
48.3
42
*
S18, ,
ICD-O-3
+∞
47.1
41
*
KMAK, ,
ICD-O-3
+∞
45.8
40
*
EB1HA, ,
ICD-O-3
+∞
44.5
39
*
SFA10, ,
ICD-O-3
+∞
44.5
39
*
SFA20, ,
ICD-O-3
+∞
44.5
39
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
43.2
38
*
R01AD09, ,
ATC
mometasone; nasal
+∞
43.2
38
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
42.0
37
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
42.0
37
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
42.0
37
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
40.7
36
*
H749, ,
ICD-10 Finland
Disorder of middle ear and mastoid, unspecified
+∞
40.7
36
*
WYA05, ,
ICD-O-3
+∞
39.5
35
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
39.5
35
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
39.5
35
*
WZC00, ,
ICD-O-3
+∞
38.3
34
*
ZXE00, ,
ICD-O-3
+∞
38.3
34
*
J069, ,
ICD-O-3
+∞
38.3
34
*
Z012, ,
ICD-O-3
+∞
37.0
33
*
ZXE10, ,
ICD-O-3
+∞
37.0
33
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
37.0
33
*
EB1SA, ,
ICD-O-3
+∞
37.0
33
*
SPAT1263, ,
ICD-O-3
+∞
37.0
33
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
37.0
33
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
35.8
32
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
35.8
32
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
35.8
32
*
SFA30, ,
ICD-O-3
+∞
35.8
32
*
ZXD10, ,
ICD-O-3
+∞
34.6
31
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
34.6
31
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
34.6
31
*
UJD10, ,
ICD-O-3
+∞
34.6
31
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
34.6
31
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
34.6
31
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
33.4
30
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
33.4
30
*
WX408, ,
ICD-O-3
+∞
33.4
30
*
H748, ,
ICD-10 Finland
Other specified disorders of middle ear and mastoid
+∞
33.4
30
*
M796, ,
ICD-O-3
+∞
33.4
30
*
SAA03, ,
ICD-O-3
+∞
33.4
30
*
SPAT1256, ,
ICD-O-3
+∞
33.4
30
*
SPAT1312, ,
ICD-O-3
+∞
32.2
29
*
-1, ,
ICD-O-3
+∞
32.2
29
*
UDC00, ,
ICD-O-3
+∞
32.2
29
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
32.2
29
*
Z871, ,
ICD-O-3
+∞
32.2
29
*
D07AC01, ,
ATC
betamethasone; topical
+∞
32.2
29
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
31.0
28
*
EBA00, ,
ICD-O-3
+∞
31.0
28
*
M02AA07, ,
ATC
piroxicam; topical
+∞
31.0
28
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
31.0
28
*
C10AA01, ,
ATC
simvastatin; oral
+∞
31.0
28
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
29.8
27
*
I10, ,
ICD-O-3
+∞
29.8
27
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
29.8
27
*
SPAT1249, ,
ICD-O-3
+∞
28.7
26
*
N05CF01, ,
ATC
zopiclone; oral
+∞
28.7
26
*
WX290, ,
ICD-O-3
+∞
28.7
26
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
28.7
26
*
E0000UV, ,
ATC
+∞
28.7
26
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
27.5
25
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
27.5
25
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
27.5
25
*
H13, ,
ICD-O-3
+∞
27.5
25
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
27.5
25
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
27.5
25
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
26.3
24
*
R05, ,
ICD-O-3
+∞
26.3
24
*
ZXA05, ,
ICD-O-3
+∞
26.3
24
*
R06AE07, ,
ATC
cetirizine; oral
+∞
26.3
24
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
26.3
24
*
D07AC13, ,
ATC
mometasone; topical
+∞
26.3
24
*
SPAT1153, ,
ICD-O-3
+∞
26.3
24
*
DFF00, ,
ICD-O-3
+∞
26.3
24
*
SPAT1223, ,
ICD-O-3
+∞
26.3
24
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
26.3
24
*
D82, ,
ICD-O-3
+∞
25.2
23
*
SPAT1325, ,
ICD-O-3
+∞
25.2
23
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
25.2
23
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
25.2
23
*
SPAT1301, ,
ICD-O-3
+∞
25.2
23
*
SDA03, ,
ICD-O-3
+∞
25.2
23
*
R74, ,
ICD-O-3
+∞
25.2
23
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
24.0
22
*
SDA02, ,
ICD-O-3
+∞
24.0
22
*
UJF32, ,
ICD-O-3
+∞
24.0
22
*
C08CA01, ,
ATC
amlodipine; oral
+∞
24.0
22
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
24.0
22
*
C03CA01, ,
ATC
furosemide; systemic
+∞
24.0
22
*
D19, ,
ICD-O-3
+∞
24.0
22
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
24.0
22
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
22.9
21
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
22.9
21
*
K0364, ,
ICD-O-3
+∞
22.9
21
*
WZA90, ,
ICD-O-3
+∞
22.9
21
*
AA1AD, ,
ICD-O-3
+∞
22.9
21
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
22.9
21
*
SPAT1253, ,
ICD-O-3
+∞
22.9
21
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
21.7
20
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
21.7
20
*
SPAT1310, ,
ICD-O-3
+∞
21.7
20
*
Z718, ,
ICD-O-3
+∞
21.7
20
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
20.6
19
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
20.6
19
*
TPH04, ,
ICD-O-3
+∞
20.6
19
*
R4110, ,
ICD-O-3
+∞
20.6
19
*
L15, ,
ICD-O-3
+∞
20.6
19
*
SDA01, ,
ICD-O-3
+∞
20.6
19
*
ZXD05, ,
ICD-O-3
+∞
20.6
19
*
N03AX16, ,
ATC
[U] pregabalin
+∞
20.6
19
*
C09AA05, ,
ATC
ramipril; oral
+∞
19.5
18
*
CJE20, ,
ICD-O-3
+∞
19.5
18
*
C09CA01, ,
ATC
losartan; oral
+∞
19.5
18
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
19.5
18
*
VALMI, ,
ICD-O-3
+∞
19.5
18
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
19.5
18
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
19.5
18
*
3858X, ,
ICD-9 Finland
Other disorders of middle ear and mastoid
+∞
19.5
18
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
19.5
18
*
K045, ,
ICD-O-3
+∞
19.5
18
*
LC2BE, ,
ICD-O-3
+∞
19.5
18
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
19.5
18
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
19.5
18
*
Z024, ,
ICD-O-3
+∞
19.5
18
*
JN3AE, ,
ICD-O-3
+∞
19.5
18
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
18.3
17
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
18.3
17
*
ZXA00, ,
ICD-O-3
+∞
18.3
17
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
18.3
17
*
SCA01, ,
ICD-O-3
+∞
18.3
17
*
N05BA04, ,
ATC
oxazepam; oral
+∞
18.3
17
*
WZB00, ,
ICD-O-3
+∞
18.3
17
*
R83, ,
ICD-O-3
+∞
18.3
17
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
18.3
17
*
WX002, ,
ICD-O-3
+∞
18.3
17
*
L03, ,
ICD-O-3
+∞
17.2
16
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
17.2
16
*
WW200, ,
ICD-O-3
+∞
17.2
16
*
Z712, ,
ICD-O-3
+∞
17.2
16
*
L17, ,
ICD-O-3
+∞
17.2
16
*
A10BA02, ,
ATC
metformin; oral
+∞
17.2
16
*
N06AB04, ,
ATC
citalopram; systemic
+∞
17.2
16
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
17.2
16
*
M01AX05, ,
ATC
glucosamine; oral
+∞
17.2
16
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
17.2
16
*
M545, ,
ICD-O-3
+∞
17.2
16
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
17.2
16
*
SDE02, ,
ICD-O-3
+∞
17.2
16
*
Z760, ,
ICD-O-3
+∞
17.2
16
*
H01, ,
ICD-O-3
+∞
17.2
16
*
H02, ,
ICD-O-3
+∞
16.1
15
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
16.1
15
*
SPAT1033, ,
ICD-O-3
+∞
16.1
15
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
16.1
15
*
M01AH01, ,
ATC
celecoxib; oral
+∞
16.1
15
*
L13, ,
ICD-O-3
+∞
16.1
15
*
R238, ,
ICD-O-3
+∞
16.1
15
*
ZXA10, ,
ICD-O-3
+∞
16.1
15
*
OAB43, ,
ICD-O-3
+∞
16.1
15
*
SPAT1254, ,
ICD-O-3
+∞
16.1
15
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
16.1
15
*
R104, ,
ICD-O-3
+∞
16.1
15
*
R21, ,
ICD-O-3
+∞
16.1
15
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
16.1
15
*
EBA05, ,
ICD-O-3
+∞
16.1
15
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
16.1
15
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
16.1
15
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
16.1
15
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
16.1
15
*
R06AX27, ,
ATC
desloratadine; oral
+∞
16.1
15
*
WZC30, ,
ICD-O-3
+∞
15.0
14
*
E000001, ,
ATC
+∞
15.0
14
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
15.0
14
*
SDA04, ,
ICD-O-3
+∞
15.0
14
*
UKC02, ,
ICD-O-3
+∞
15.0
14
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
15.0
14
*
GD1QA, ,
ICD-O-3
+∞
15.0
14
*
D01BA02, ,
ATC
terbinafine; oral
+∞
15.0
14
*
L82, ,
ICD-O-3
+∞
15.0
14
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
15.0
14
*
Z2221, ,
ICD-O-3
+∞
15.0
14
*
FM1EE, ,
ICD-O-3
+∞
15.0
14
*
M706, ,
ICD-O-3
+∞
15.0
14
*
R53, ,
ICD-O-3
+∞
15.0
14
*
SPAT1250, ,
ICD-O-3
+∞
15.0
14
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
15.0
14
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
15.0
14
*
WX404, ,
ICD-O-3
+∞
15.0
14
*
SPAT1148, ,
ICD-O-3
+∞
15.0
14
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
13.9
13
*
B01AA03, ,
ATC
warfarin; systemic
+∞
13.9
13
*
XF400, ,
ICD-O-3
+∞
13.9
13
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
13.9
13
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
13.9
13
*
Z3231, ,
ICD-O-3
+∞
13.9
13
*
GD1UA, ,
ICD-O-3
+∞
13.9
13
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
13.9
13
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
13.9
13
*
DCA20, ,
ICD-O-3
+∞
13.9
13
*
K0382, ,
ICD-O-3
+∞
13.9
13
*
SFC01, ,
ICD-O-3
+∞
13.9
13
*
L08, ,
ICD-O-3
+∞
13.9
13
*
Z017, ,
ICD-O-3
+∞
13.9
13
*
C09CA06, ,
ATC
candesartan; oral
+∞
13.9
13
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
13.9
13
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
13.9
13
*
M01AX17, ,
ATC
nimesulide; oral
+∞
13.9
13
*
J010, ,
ICD-O-3
+∞
13.9
13
*
A28, ,
ICD-O-3
+∞
13.9
13
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
13.9
13
*
M545, ,
ICD-10 Finland
Low back pain
+∞
13.9
13
*
J209, ,
ICD-O-3
+∞
12.8
12
*
S82, ,
ICD-O-3
+∞
12.8
12
*
Z719, ,
ICD-O-3
+∞
12.8
12
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
12.8
12
*
WX402, ,
ICD-O-3
+∞
12.8
12
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
12.8
12
*
Z3226, ,
ICD-O-3
+∞
12.8
12
*
SFA40, ,
ICD-O-3
+∞
12.8
12
*
SPAT1097, ,
ICD-O-3
+∞
12.8
12
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
12.8
12
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
12.8
12
*
C07AA05, ,
ATC
propranolol; systemic
+∞
12.8
12
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
12.8
12
*
A03, ,
ICD-O-3
+∞
12.8
12
*
H81, ,
ICD-O-3
+∞
12.8
12
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
12.8
12
*
T90, ,
ICD-O-3
+∞
12.8
12
*
J010, ,
ICD-10 Finland
Acute maxillary sinusitis
+∞
12.8
12
*
FN1AC, ,
ICD-O-3
+∞
12.8
12
*
R03DC03, ,
ATC
montelukast; oral
+∞
12.8
12
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
12.8
12
*
206, ,
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
+∞
12.8
12
*
C09AA02, ,
ATC
enalapril; systemic
+∞
12.8
12
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
12.8
12
*
J01FA15, ,
ATC
telithromycin; oral
+∞
11.7
11
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
11.7
11
*
ZX120, ,
ICD-O-3
+∞
11.7
11
*
R03AC03, ,
ATC
terbutaline; inhalant
+∞
11.7
11
*
N06AB10, ,
ATC
escitalopram; oral
+∞
11.7
11
*
I839, ,
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
+∞
11.7
11
*
R060, ,
ICD-O-3
+∞
11.7
11
*
TDA90, ,
ICD-O-3
+∞
11.7
11
*
H29, ,
ICD-O-3
+∞
11.7
11
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
11.7
11
*
U071, ,
ICD-O-3
+∞
11.7
11
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
11.7
11
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
11.7
11
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
11.7
11
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
11.7
11
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
11.7
11
*
R5110, ,
ICD-O-3
+∞
11.7
11
*
G560, ,
ICD-10 Finland
Carpal tunnel syndrome
+∞
11.7
11
*
A97, ,
ICD-O-3
+∞
11.7
11
*
202, ,
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
11.7
11
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
11.7
11
*
E780, ,
ICD-O-3
+∞
11.7
11
*
SPAT1260, ,
ICD-O-3
+∞
11.7
11
*
M255, ,
ICD-O-3
+∞
11.7
11
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
11.7
11
*
N02CC01, ,
ATC
sumatriptan; nasal, systemic, rectal
+∞
11.7
11
*
SGA01, ,
ICD-O-3
+∞
11.7
11
*
SDE03, ,
ICD-O-3
+∞
11.7
11
*
H660, ,
ICD-10 Finland
Acute suppurative otitis media
+∞
11.7
11
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
11.7
11
*
H603, ,
ICD-10 Finland
Other infective otitis externa
+∞
11.7
11
*
H609, ,
ICD-O-3
+∞
11.7
11
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
11.7
11
*
SPAT1230, ,
ICD-O-3
+∞
11.7
11
*
Z014, ,
ICD-10 Finland
Gynaecological examination (general)(routine)
+∞
11.7
11
*
S29, ,
ICD-O-3
+∞
11.7
11
*
N05BA01, ,
ATC
diazepam; systemic, rectal
+∞
11.7
11
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
11.7
11
*
Z258, ,
ICD-O-3
+∞
11.7
11
*
WX700, ,
ICD-O-3
+∞
10.6
10
*
G03DB01, ,
ATC
dydrogesterone; oral
+∞
10.6
10
*
WX320, ,
ICD-O-3
+∞
10.6
10
*
E119, ,
ICD-O-3
+∞
10.6
10
*
50099, ,
ICD-8 Finland
Hypertrophy of tonsils and adenoids
+∞
10.6
10
*
B01AF01, ,
ATC
rivaroxaban; oral
+∞
10.6
10
*
SPAT1262, ,
ICD-O-3
+∞
10.6
10
*
DCA10, ,
ICD-O-3
+∞
10.6
10
*
M751, ,
ICD-10 Finland
Rotator cuff syndrome
+∞
10.6
10
*
L01, ,
ICD-O-3
+∞
10.6
10
*
Z3229, ,
ICD-O-3
+∞
10.6
10
*
NGD05, ,
ICD-O-3
+∞
10.6
10
*
M531, ,
ICD-O-3
+∞
10.6
10
*
C10AX09, ,
ATC
ezetimibe; oral
+∞
10.6
10
*
SGA02, ,
ICD-O-3
+∞
10.6
10
*
AA1CG, ,
ICD-O-3
+∞
10.6
10
*
SPAT1222, ,
ICD-O-3
+∞
10.6
10
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
10.6
10
*
H71, ,
ICD-10 Finland
Cholesteatoma of middle ear
+∞
10.6
10
*
H02AB07, ,
ATC
prednisone; oral
+∞
10.6
10
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
10.6
10
*
P06, ,
ICD-O-3
+∞
10.6
10
*
D07AB08, ,
ATC
desonide; topical
+∞
10.6
10
*
R06AX22, ,
ATC
ebastine; oral
+∞
10.6
10
*
R2130, ,
ICD-O-3
+∞
10.6
10
*
H652, ,
ICD-10 Finland
Chronic serous otitis media
+∞
10.6
10
*
K86, ,
ICD-O-3
+∞
10.6
10
*
ND2AA, ,
ICD-O-3
+∞
10.6
10
*
F510, ,
ICD-O-3
+∞
10.6
10
*
TQX10, ,
ICD-O-3
+∞
10.6
10
*
L12, ,
ICD-O-3
+∞
10.6
10
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
10.6
10
*
R02, ,
ICD-O-3
+∞
10.6
10
*
K802, ,
ICD-10 Finland
Calculus of gallbladder without cholecystitis
+∞
10.6
10
*
M232, ,
ICD-10 Finland
Derangement of meniscus due to old tear or injury
+∞
10.6
10
*
AA1BG, ,
ICD-O-3
+∞
10.6
10
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
9.5
9
*
H901, ,
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
9.5
9
*
NGB20, ,
ICD-O-3
+∞
9.5
9
*
J01AA04, ,
ATC
lymecycline; systemic
+∞
9.5
9
*
R5140, ,
ICD-O-3
+∞
9.5
9
*
U072, ,
ICD-O-3
+∞
9.5
9
*
H653, ,
ICD-10 Finland
Chronic mucoid otitis media
+∞
9.5
9
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
9.5
9
*
Z0389, ,
ICD-10 Finland
Observation for other suspected diseases and conditions
+∞
9.5
9
*
Z974, ,
ICD-10 Finland
Presence of external hearing-aid
+∞
9.5
9
*
M544, ,
ICD-O-3
+∞
9.5
9
*
S060, ,
ICD-10 Finland
Concussion
+∞
9.5
9
*
ZXD20, ,
ICD-O-3
+∞
9.5
9
*
XKD00, ,
ICD-O-3
+∞
9.5
9
*
K219, ,
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
+∞
9.5
9
*
M170, ,
ICD-10 Finland
Primary gonarthrosis, bilateral
+∞
9.5
9
*
R09, ,
ICD-O-3
+∞
9.5
9
*
UDH02, ,
ICD-O-3
+∞
9.5
9
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
9.5
9
*
H920, ,
ICD-O-3
+∞
9.5
9
*
M54, ,
ICD-O-3
+∞
9.5
9
*
UDQ12, ,
ICD-O-3
+∞
9.5
9
*
M511, ,
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
+∞
9.5
9
*
M480, ,
ICD-10 Finland
Spinal stenosis
+∞
9.5
9
*
SPAT1216, ,
ICD-O-3
+∞
9.5
9
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
9.5
9
*
L28, ,
ICD-O-3
+∞
9.5
9
*
AN1, ,
ICD-O-3
+∞
9.5
9
*
N05CF02, ,
ATC
zolpidem; oral
+∞
9.5
9
*
OAA65, ,
ICD-O-3
+∞
9.5
9
*
M751, ,
ICD-O-3
+∞
9.5
9
*
R5180, ,
ICD-10 Finland
Headache
+∞
9.5
9
*
K0365, ,
ICD-O-3
+∞
9.5
9
*
I48, ,
ICD-O-3
+∞
9.5
9
*
Z011, ,
ICD-O-3
+∞
9.5
9
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
9.5
9
*
XF600, ,
ICD-O-3
+∞
8.5
8
*
R55, ,
ICD-10 Finland
Syncope and collapse
+∞
8.5
8
*
C09CA07, ,
ATC
telmisartan; oral
+∞
8.5
8
*
Z048, ,
ICD-10 Finland
Examination and observation for other specified reasons
+∞
8.5
8
*
M171, ,
ICD-O-3
+∞
8.5
8
*
J320, ,
ICD-10 Finland
Chronic maxillary sinusitis
+∞
8.5
8
*
6500B, ,
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
+∞
8.5
8
*
N06AB06, ,
ATC
sertraline; oral
+∞
8.5
8
*
N06CA01, ,
ATC
amitriptyline and psycholeptics; systemic
+∞
8.5
8
*
D07BB04, ,
ATC
hydrocortisone butyrate and antiseptics; topical
+∞
8.5
8
*
J01, ,
ICD-O-3
+∞
8.5
8
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
8.5
8
*
C08CA02, ,
ATC
felodipine; oral
+∞
8.5
8
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
8.5
8
*
F29, ,
ICD-O-3
+∞
8.5
8
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
8.5
8
*
LC2AE, ,
ICD-O-3
+∞
8.5
8
*
J01MA06, ,
ATC
norfloxacin; oral
+∞
8.5
8
*
NA3AA, ,
ICD-O-3
+∞
8.5
8
*
R06AX13, ,
ATC
loratadine; oral
+∞
8.5
8
*
J189, ,
ICD-O-3
+∞
8.5
8
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
8.5
8
*
J05AB11, ,
ATC
valaciclovir; oral
+∞
8.5
8
*
A06AD11, ,
ATC
lactulose; oral
+∞
8.5
8
*
M02AA10, ,
ATC
ketoprofen; topical
+∞
8.5
8
*
S610, ,
ICD-10 Finland
Open wound of finger(s) without damage to nail
+∞
8.5
8
*
ZY020, ,
ICD-O-3
+∞
8.5
8
*
WX105, ,
ICD-O-3
+∞
8.5
8
*
H906, ,
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
8.5
8
*
SPAT1305, ,
ICD-O-3
+∞
8.5
8
*
Z712, ,
ICD-10 Finland
Person consulting for explanation of investigation findings
+∞
8.5
8
*
A29, ,
ICD-O-3
+∞
8.5
8
*
HA1AE, ,
ICD-O-3
+∞
8.5
8
*
O800, ,
ICD-10 Finland
Spontaneous vertex delivery
+∞
8.5
8
*
DAX00, ,
ICD-O-3
+∞
8.5
8
*
R103, ,
ICD-O-3
+∞
8.5
8
*
D07AD01, ,
ATC
clobetasol; topical
+∞
8.5
8
*
SGA03, ,
ICD-O-3
+∞
8.5
8
*
N05AH04, ,
ATC
quetiapine; oral
+∞
8.5
8
*
SPAT1156, ,
ICD-O-3
+∞
8.5
8
*
K020, ,
ICD-O-3
+∞
8.5
8
*
DM1QA, ,
ICD-O-3
+∞
8.5
8
*
H02AB02, ,
ATC
dexamethasone; systemic
+∞
8.5
8
*
JN3AD, ,
ICD-O-3
+∞
8.5
8
*
SFA00, ,
ICD-O-3
+∞
8.5
8
*
N300, ,
ICD-10 Finland
Acute cystitis
+∞
8.5
8
*
XX3DW, ,
ICD-O-3
+∞
8.5
8
*
N40, ,
ICD-O-3
+∞
8.5
8
*
K0530, ,
ICD-O-3
+∞
8.5
8
*
KC1EE, ,
ICD-O-3
+∞
8.5
8
*
U02, ,
ICD-O-3
+∞
8.5
8
*
H660, ,
ICD-O-3
+∞
8.5
8
*
E11, ,
ICD-O-3
+∞
8.5
8
*
N01, ,
ICD-O-3
+∞
8.5
8
*
L04AX03, ,
ATC
methotrexate; systemic
+∞
8.5
8
*
SPAT1149, ,
ICD-O-3
+∞
8.5
8
*
Z301, ,
ICD-O-3
+∞
8.5
8
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
8.5
8
*
L02, ,
ICD-O-3
+∞
8.5
8
*
Z035, ,
ICD-10 Finland
Observation for other suspected cardiovascular diseases
+∞
8.5
8
*
SHB00, ,
ICD-O-3
+∞
8.5
8
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
8.5
8
*
S04, ,
ICD-O-3
+∞
8.5
8
*
I251, ,
ICD-O-3
+∞
7.4
7
*
SGB30, ,
ICD-O-3
+∞
7.4
7
*
H811, ,
ICD-O-3
+∞
7.4
7
*
Z461, ,
ICD-10 Finland
Fitting and adjustment of hearing aid
+∞
7.4
7
*
R29, ,
ICD-O-3
+∞
7.4
7
*
M01AG02, ,
ATC
tolfenamic acid; oral, rectal
+∞
7.4
7
*
C03DA01, ,
ATC
spironolactone; oral
+∞
7.4
7
*
B01AF02, ,
ATC
apixaban; oral
+∞
7.4
7
*
SPAT1058, ,
ICD-O-3
+∞
7.4
7
*
R101, ,
ICD-10 Finland
Pain localized to upper abdomen
+∞
7.4
7
*
NG1AA, ,
ICD-O-3
+∞
7.4
7
*
N390, ,
ICD-O-3
+∞
7.4
7
*
SPAT1043, ,
ICD-O-3
+∞
7.4
7
*
NH3AA, ,
ICD-O-3
+∞
7.4
7
*
EBA10, ,
ICD-O-3
+∞
7.4
7
*
JN3BD, ,
ICD-O-3
+∞
7.4
7
*
OAB50, ,
ICD-O-3
+∞
7.4
7
*
SPAT1283, ,
ICD-O-3
+∞
7.4
7
*
SHA01, ,
ICD-O-3
+∞
7.4
7
*
SGB10, ,
ICD-O-3
+∞
7.4
7
*
TDM10, ,
ICD-O-3
+∞
7.4
7
*
Y83, ,
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
7.4
7
*
M544, ,
ICD-10 Finland
Lumbago with sciatica
+∞
7.4
7
*
L309, ,
ICD-10 Finland
Dermatitis, unspecified
+∞
7.4
7
*
G03AC03, ,
ATC
levonorgestrel; oral, implant
+∞
7.4
7
*
D11, ,
ICD-O-3
+∞
7.4
7
*
R298, ,
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
+∞
7.4
7
*
TQW40, ,
ICD-O-3
+∞
7.4
7
*
G04CA01, ,
ATC
alfuzosin; oral
+∞
7.4
7
*
JKA21, ,
ICD-O-3
+∞
7.4
7
*
DFF15, ,
ICD-O-3
+∞
7.4
7
*
K30, ,
ICD-10 Finland
Functional dyspepsia
+∞
7.4
7
*
A06AC51, ,
ATC
ispaghula, combinations; oral
+∞
7.4
7
*
R600, ,
ICD-O-3
+∞
7.4
7
*
SPAT1308, ,
ICD-O-3
+∞
7.4
7
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
7.4
7
*
S01GX02, ,
ATC
levocabastine; ophthalmic
+∞
7.4
7
*
WYA30, ,
ICD-O-3
+∞
7.4
7
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
7.4
7
*
A02BA04, ,
ATC
nizatidine; systemic
+∞
7.4
7
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
7.4
7
*
N300, ,
ICD-O-3
+∞
7.4
7
*
D259, ,
ICD-10 Finland
Leiomyoma of uterus, unspecified
+∞
7.4
7
*
J01DA08, ,
ATC
[U] cefaclor
+∞
7.4
7
*
K0531, ,
ICD-O-3
+∞
7.4
7
*
J451, ,
ICD-10 Finland
Nonallergic asthma
+∞
7.4
7
*
G03FA01, ,
ATC
norethisterone and estrogen; systemic
+∞
7.4
7
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
7.4
7
*
C08CA13, ,
ATC
lercanidipine; oral
+∞
7.4
7
*
FM1AE, ,
ICD-O-3
+∞
7.4
7
*
SBB10, ,
ICD-O-3
+∞
7.4
7
*
N05CD07, ,
ATC
temazepam; oral
+∞
7.4
7
*
I509, ,
ICD-O-3
+∞
7.4
7
*
R01AD11, ,
ATC
triamcinolone; nasal
+∞
7.4
7
*
SPAT1306, ,
ICD-O-3
+∞
7.4
7
*
S02CA02, ,
ATC
flumetasone and antiinfectives; otic
+∞
7.4
7
*
NF1AA, ,
ICD-O-3
+∞
7.4
7
*
H669, ,
ICD-10 Finland
Otitis media, unspecified
+∞
7.4
7
*
C05AA08, ,
ATC
fluocortolone; rectal, topical
+∞
7.4
7
*
P20, ,
ICD-O-3
+∞
7.4
7
*
XLD00, ,
ICD-O-3
+∞
7.4
7
*
R42, ,
ICD-O-3
+∞
7.4
7
*
A09, ,
ICD-O-3
+∞
7.4
7
*
J310, ,
ICD-10 Finland
Chronic rhinitis
+∞
7.4
7
*
A03FA02, ,
ATC
cisapride; oral, rectal
+∞
7.4
7
*
J450, ,
ICD-10 Finland
Predominantly allergic asthma
+∞
7.4
7
*
K0366, ,
ICD-O-3
+∞
7.4
7
*
OAB48, ,
ICD-O-3
+∞
7.4
7
*
NA3BG, ,
ICD-O-3
+∞
7.4
7
*
R5130, ,
ICD-O-3
+∞
7.4
7
*
DM1AA, ,
ICD-O-3
+∞
7.4
7
*
H741, ,
ICD-10 Finland
Adhesive middle ear disease
+∞
7.4
7
*
I509, ,
ICD-10 Finland
Heart failure, unspecified
+∞
7.4
7
*
SPAT1053, ,
ICD-O-3
+∞
7.4
7
*
TDW99, ,
ICD-O-3
+∞
7.4
7
*
D05AX52, ,
ATC
calcipotriol, combinations; topical
+∞
7.4
7
*
G473, ,
ICD-O-3
+∞
7.4
7
*
WX702, ,
ICD-O-3
+∞
7.4
7
*
Z769, ,
ICD-10 Finland
Person encountering health services in unspecified circumstances
+∞
6.3
6
*
DC1AD, ,
ICD-O-3
+∞
6.3
6
*
J01MA14, ,
ATC
moxifloxacin; systemic
+∞
6.3
6
*
M161, ,
ICD-10 Finland
Other primary coxarthrosis
+∞
6.3
6
*
M201, ,
ICD-10 Finland
Hallux valgus (acquired)
+∞
6.3
6
*
Z100, ,
ICD-O-3
+∞
6.3
6
*
FN1YT, ,
ICD-O-3
+∞
6.3
6
*
N63, ,
ICD-O-3
+∞
6.3
6
*
H669, ,
ICD-O-3
+∞
6.3
6
*
Z014, ,
ICD-O-3
+∞
6.3
6
*
N02BF01, ,
ATC
gabapentin; oral
+∞
6.3
6
*
130, ,
Kela drug reimbursment
Malignant tumour
+∞
6.3
6
*
D07XC01, ,
ATC
betamethasone; topical
+∞
6.3
6
*
XQ800, ,
ICD-O-3
+∞
6.3
6
*
S08, ,
ICD-O-3
+∞
6.3
6
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
6.3
6
*
L11, ,
ICD-O-3
+∞
6.3
6
*
M09AX01, ,
ATC
hyaluronic acid; parenteral
+∞
6.3
6
*
M530, ,
ICD-O-3
+∞
6.3
6
*
38100, ,
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
6.3
6
*
R05, ,
ICD-10 Finland
Cough
+∞
6.3
6
*
A11, ,
ICD-O-3
+∞
6.3
6
*
D07CC01, ,
ATC
betamethasone and antibiotics; topical
+∞
6.3
6
*
N950, ,
ICD-10 Finland
Postmenopausal bleeding
+∞
6.3
6
*
H66, ,
ICD-O-3
+∞
6.3
6
*
L721, ,
ICD-O-3
+∞
6.3
6
*
XCK10, ,
ICD-O-3
+∞
6.3
6
*
CK2X4, ,
ICD-O-3
+∞
6.3
6
*
A05, ,
ICD-O-3
+∞
6.3
6
*
C10AA04, ,
ATC
fluvastatin; oral
+∞
6.3
6
*
SPAT1292, ,
ICD-O-3
+∞
6.3
6
*
QAE10, ,
ICD-O-3
+∞
6.3
6
*
Z008, ,
ICD-10 Finland
Other general examinations
+∞
6.3
6
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
6.3
6
*
F03, ,
ICD-O-3
+∞
6.3
6
*
J209, ,
ICD-10 Finland
Acute bronchitis, unspecified
+∞
6.3
6
*
Z000, ,
ICD-O-3
+∞
6.3
6
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
6.3
6
*
FM1DE, ,
ICD-O-3
+∞
6.3
6
*
N06AA09, ,
ATC
amitriptyline; systemic
+∞
6.3
6
*
WW500, ,
ICD-O-3
+∞
6.3
6
*
OAA67, ,
ICD-O-3
+∞
6.3
6
*
R33, ,
ICD-10 Finland
Retention of urine
+∞
6.3
6
*
J20, ,
ICD-O-3
+∞
6.3
6
*
N40, ,
ICD-10 Finland
Hyperplasia of prostate
+∞
6.3
6
*
JN4AD, ,
ICD-O-3
+∞
6.3
6
*
Z508, ,
ICD-10 Finland
Care involving use of other rehabilitation procedures
+∞
6.3
6
*
I2081, ,
ICD-10 Finland
Other angina pectoris stenosed coronary artery
+∞
6.3
6
*
R229, ,
ICD-O-3
+∞
6.3
6
*
N394, ,
ICD-10 Finland
Other specified urinary incontinence
+∞
6.3
6
*
G04BD08, ,
ATC
solifenacin; oral
+∞
6.3
6
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
6.3
6
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
6.3
6
*
NJ2MA, ,
ICD-O-3
+∞
6.3
6
*
XF404, ,
ICD-O-3
+∞
6.3
6
*
D01, ,
ICD-O-3
+∞
6.3
6
*
KH1AE, ,
ICD-O-3
+∞
6.3
6
*
K85, ,
ICD-O-3
+∞
6.3
6
*
H664, ,
ICD-10 Finland
Suppurative otitis media, unspecified
+∞
6.3
6
*
XF402, ,
ICD-O-3
+∞
6.3
6
*
WZC05, ,
ICD-O-3
+∞
6.3
6
*
WZC20, ,
ICD-O-3
+∞
6.3
6
*
SPAT1281, ,
ICD-O-3
+∞
6.3
6
*
DAX08, ,
ICD-O-3
+∞
6.3
6
*
R05DB20, ,
ATC
other cough suppressants - combinations
+∞
6.3
6
*
Z039, ,
ICD-O-3
+∞
6.3
6
*
A07EC01, ,
ATC
sulfasalazine; oral, rectal
+∞
6.3
6
*
TKC20, ,
ICD-O-3
+∞
6.3
6
*
G01AA10, ,
ATC
clindamycin; vaginal
+∞
6.3
6
*
6421, ,
ICD-O-3
+∞
6.3
6
*
K210, ,
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
+∞
6.3
6
*
SXC05, ,
ICD-O-3
+∞
6.3
6
*
R21, ,
ICD-10 Finland
Rash and other nonspecific skin eruption
+∞
6.3
6
*
H438, ,
ICD-10 Finland
Other disorders of vitreous body
+∞
6.3
6
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
6.3
6
*
L309, ,
ICD-O-3
+∞
6.3
6
*
E039, ,
ICD-O-3
+∞
6.3
6
*
F419, ,
ICD-O-3
+∞
6.3
6
*
H920, ,
ICD-10 Finland
Otalgia
+∞
6.3
6
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
6.3
6
*
ZYC01, ,
ICD-O-3
+∞
6.3
6
*
SGA04, ,
ICD-O-3
+∞
6.3
6
*
R91, ,
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
+∞
6.3
6
*
L16, ,
ICD-O-3
+∞
6.3
6
*
G04CB01, ,
ATC
finasteride; oral
+∞
6.3
6
*
S03CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic, otic
+∞
6.3
6
*
S21, ,
ICD-O-3
+∞
6.3
6
*
R03BB04, ,
ATC
tiotropium bromide; inhalant
+∞
6.3
6
*
M179, ,
ICD-O-3
+∞
6.3
6
*
ZXE20, ,
ICD-O-3
+∞
6.3
6
*
N920, ,
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
+∞
6.3
6
*
S97, ,
ICD-O-3
+∞
6.3
6
*
N17, ,
ICD-O-3
+∞
6.3
6
*
JN4BD, ,
ICD-O-3
+∞
6.3
6
*
3859X, ,
ICD-9 Finland
Other disorders of middle ear and mastoid, Unspecified disorder of middle ear and mastoid
+∞
6.3
6
*
H907, ,
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
6.3
6
*
N07CA01, ,
ATC
betahistine; oral
+∞
6.3
6
*
R074, ,
ICD-O-3
+∞
6.3
6
*
K0510, ,
ICD-O-3
+∞
6.3
6
*
LX1AE, ,
ICD-O-3
+∞
6.3
6
*
SPAT1217, ,
ICD-O-3
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
6
10
6.33
2.74
7.3
3.2
53.00
60.20
%
—
6
10
30
176
2.05
2.47
1.5
1.7
1.82
1.18
mg/l
0.32
22
142
22
123
2.04
2.03
1.4
1.3
28.64
39.27
iu/ml
—
7
41
9
33
2.91
1.99
4.9
5.3
44.99
47.84
%
—
9
33
9
33
2.91
1.99
3.7
5.3
24.01
24.25
mmol/l
—
9
33
24
140
1.97
1.97
1.6
1.8
347368809.74
460.15
pmol/l
0.48
19
115
16
81
2.18
1.88
4.9
6.3
1.07
1.04
mmol/l
0.24
16
74
15
74
2.23
1.87
1.6
1.6
—
—
—
0
0
66
538
1.85
1.77
5.6
4.3
11.53
11.96
mm/h
0.09
59
497
15
76
2.17
1.76
1.6
1.8
—
—
—
0
0
16
88
1.99
1.53
4.0
6.9
104.06
103.97
mmol/l
0.02
16
88
17
102
1.82
1.27
1.7
1.8
—
—
—
0
0
12
64
2.01
1.24
3.2
1.8
294.75
362.54
nmol/l
0.44
12
59
18
115
1.70
1.10
1.4
1.3
1.72
8.84
u/ml
—
8
46
7
33
2.21
1.08
2.3
1.4
—
—
—
0
0
12
69
1.85
1.02
3.3
3.7
—
—
—
0
0
64
554
1.53
1.01
4.7
4.1
14.68
14.98
pmol/l
0.34
57
501
77
696
1.73
1.00
5.6
4.6
5.82
5.92
mmol/l
0.40
72
640
9
50
1.89
1.00
2.9
2.4
95.22
278.94
ng/l
—
9
45
35
275
1.44
0.87
4.0
3.9
21.55
33.12
ng/l
0.54
29
187
44
362
1.42
0.85
6.1
4.0
0.00
0.00
estimate
-0.00
11
70
44
363
1.41
0.83
7.5
5.5
0.00
0.00
estimate
-0.00
11
61
8
48
1.73
0.81
1.9
1.2
—
—
—
0
0
6
33
1.87
0.80
1.5
1.3
—
—
—
0
0
36
289
1.41
0.79
6.6
4.3
—
—
—
0
0
35
282
1.39
0.74
2.2
1.9
83.25
98.47
pmol/l
1.53
21
135
26
200
1.42
0.71
7.3
4.3
0.00
0.00
estimate
-0.00
11
61
44
371
1.36
0.70
6.1
4.0
0.00
0.00
estimate
—
10
64
41
344
1.35
0.67
7.8
7.0
1.19
1.22
mmol/l
1.17
34
295
25
196
1.38
0.61
2.0
1.7
1.48
1.36
mmol/l
0.35
16
166
73
677
1.41
0.56
5.7
4.8
1.99
1.92
mu/l
0.17
68
612
39
335
1.29
0.51
18.8
12.3
1.39
1.31
inr
0.18
11
98
18
138
1.38
0.50
1.3
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
32.53
—
0
17
6
89
0.65
0.35
4.2
4.6
32.67
33.03
%
—
6
58
32
281
1.21
0.32
5.3
3.1
—
—
—
0
0
72
690
1.21
0.24
17.5
13.1
83.06
80.97
ml/min/173m2
0.38
59
556
5
37
1.37
0.24
2.0
2.9
1.74
0.92
%
—
5
37
5
37
1.37
0.24
1.2
1.4
—
—
—
0
0
83
808
1.34
0.24
30.7
20.6
133.70
135.25
g/l
0.43
83
796
25
221
1.18
0.23
2.5
3.6
18.77
9.08
mg/mmol
0.42
14
138
21
183
1.19
0.22
1.2
1.3
0.69
1.02
u/ml
—
8
57
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
2.75
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
6
49
1.24
0.20
1.3
1.7
—
—
—
0
0
45
479
0.88
0.20
3.3
2.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
38
352
1.14
0.19
2.2
2.2
—
—
—
0
0
6
77
0.76
0.16
1.8
1.6
1.27
1.33
%
—
6
67
7
85
0.81
0.15
1.9
1.9
—
—
—
0
0
10
115
0.85
0.11
1.6
1.4
—
—
—
0
0
10
87
1.17
0.10
17.5
8.5
—
—
—
0
0
18
165
1.11
0.09
1.9
1.9
—
—
—
0
0
7
65
1.08
0.08
2.3
2.7
29.29
30.61
u/l
—
7
56
66
645
1.08
0.07
23.9
16.5
14.00
14.95
%
1.55
66
638
7
80
0.86
0.07
1.9
1.8
—
—
—
0
0
78
772
1.07
0.02
24.4
15.9
78.72
76.32
umol/l
0.22
78
772
73
729
1.00
0.00
21.2
14.1
20.04
23.69
mg/l
0.61
63
576
16
158
1.01
0.00
5.1
4.5
21.21
21.28
%
—
7
80
0
6
0.00
-0.00
0.0
1.7
—
7.97
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
18.00
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
43.60
—
0
5
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
19.34
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_MIDDMASTNAS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_MIDDMASTNAS | 1.128 [0.74, 1.72] | 0.576 |
| Birth year | 0.982 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 55 out of 259 males with H8_MIDDMASTNAS died.
Mortality risk
Mortality risk for people of age
years, who have H8_MIDDMASTNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.187% |
| 5 | No data | 1.065% |
| 10 | No data | 2.818% |
| 15 | No data | 5.374% |
| 20 | No data | 9.128% |
Relationships between endpoints
↥Index endpoint: H8_MIDDMASTNAS – Other specified/unspecified disorders of middle ear and mastoid
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data